Outcome of kidney transplantation in patients with inherited thrombophilia: Data of a prospective study

Journal of the American Society of Nephrology

Volumn 14, Issue 1, 2003, Pages 234-239

  Heidenreich, Stefan ^a,b   Junker, Ralf ^a   Wolters, Heiner ^a   Lang, Detlef ^a   Hessing, Sabine ^a   Nitsche, Gitta ^a   Nowak Göttl, Ulrike ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Department of Medicine D ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTITHROMBIN; BLOOD CLOTTING FACTOR 5; PROTEIN C; PROTEIN S; PROTHROMBIN;

ARTICLE; FEMALE; GENE MUTATION; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA; TREATMENT INDICATION; VEIN THROMBOSIS;

EID: 12244302881     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000039567.22063.9D     Document Type: Article

References (29)

1. Takemoto S, Terasaki PI, Cecka JM, Cho YW, Gjertson DW: Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. N Engl J Med 327: 834-839, 1992
2. Gruber SA, Chavers B, Payne WD, Jamil F, Warrik C: Allograft renal vascular thrombosis. Transplantation 47: 475-478, 1989
3. Singh A, Stablein D, Tejani A: Risk factors for vascular thrombosis in pediatric renal transplantation. Transplantation 63: 1263-1267, 1997
4. Neild GH, Reuben R, Hartley RB, Cameron JS: Glomerular thrombi in renal allografts associated with cyclosporin treatment. J Clin Pathol 38: 253-258, 1985
5. Mauiyyedi S, Crespo M, Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Tolkoff-Rubin NE, Williams WW, Delmonico FL, Cosimi AB, Colvin RB: Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 13: 779-787, 2002
6. Heidenreich S, Dercken C, August C, Koch HG, Nowak-Göttl U: High rate of acute rejections in renal allograft recipients with thrombophilic risk factors. J Am Soc Nephrol 9: 1309-1313, 1998
7. Fischereder M, Göhring P, Schneeberger H, Lohse P, Von Appen K, Samtleben W, Schöndorff D, Land W: Early loss of renal transplants in patients with thrombophilia. Transplantation 65: 936-939, 1998
8. Hocher B, Slowinski T, Hauser I, Vetter B, Fritschel L, Bachert D, Kulozik A, Neumayer HH: Association of factor V Leiden mutation with delayed graft function, acute rejection episodes and long-term graft dysfunction in kidney transplant recipients. Thromb Haemost 87: 194-198, 2002
9. Irish AB, Green FR, Gray DWR, Morris PJ: The factor V Leiden (R506Q) mutation and risk of thrombosis in renal transplant recipients. Transplantation 64: 604-607, 1997
10. Ekberg H, Svensson PJ, Simanaitis M, Dahlbäck B: Factor V R505Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection. Transplantation 69: 1577-1581, 2000
11. Wüthrich RP, Cicvara-Muzar S, Booy C, Maly FE: Heterozygosity for the factor V Leiden (G1691A) mutation predisposes renal transplant recipients to thrombotic complications and graft loss. Transplantation 72: 549-550, 2001
12. Fischereder M, Schneeberger H, Lohse P, Krämer BK, Schlön-dorff D, Land W: Increased rate of renal transplant failure in patients with the G20210A mutation of the prothrombin gene. Am J Kidney Dis 38: 1061-1064, 2001
13. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369: 64-67, 1994
14. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and increase in venous thrombosis. Blood 88: 3698-3703, 1996
15. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP: A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nature Genet 10: 111-113, 1995
16. Junker R, Koch HG, Auberger K, Münchow N, Ehrenforth S, Nowak-Göttl U: Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol 19: 2568-2572, 1999
17. Racusen LC, Solez K, Colvin RB: The Banff 97 working classification of renal allograft pathology. Kidney Int 55: 713-723, 1999
18. Welch GN, Loscalzo J: Homocysteine and atherothrombosis. N Engl J Med 338: 1042-1050, 1998
19. Naldini A, Carney DH, Bocci V, Klimpel KD, Asuncion M, Soares LE, Klimpel GR: Thrombin enhances T cell proliferative responses and cytokine production. Cell Immunol 147: 367-377, 1993
20. Naldini A, Carney DH, Bocci V, Klimpel KD, Asuncion M, Soares LE, Klimpel GR: The serine protease cofactor factor V is synthesized by lymphocytes. J Immunol 150: 2992-3001, 1993
21. Heidenreich S, Nowak-Göttl U, August C: Hypercoagulable state and graft rejection - Is there a link? Nephrol Dial Transplant 14: 2293-2296, 1999
22. Liangos O, Kreutz R, Beige J, Offermann G, Distler A, Sharma AM: Methylenetetrahydrofolate-reductase gene C677T variant and kidney-transplant survival. Nephrol Dial Transplant 13: 2351-2354, 1998
23. Pethig K, Hoffmann A, Heublein B, Timke A, Gross G, Haverich A: Cardiac allograft vascular disease after orthotopic heart transplantation: Methylenetetrahydrofolate reductase gene polymorphism C677T does not account for rapidly progressive forms. Transplantation 69: 442-445, 2000
24. Huisman MV, Rosendaal F: Thrombophilia. Curr Opin Hematol 6: 291-297, 1999
25. Franco RF, Reitsma PH: Genetic risk factors of venous thrombosis. Hum Genet 109: 369-384, 2001
26. Desmarais S, de Moerloose P, Reber G, Minazio P, Perrier A, Bounameaux H: Resistance to activated protein C in an unselected population of patients with pulmonary embolism. Lancet 347: 1374-1375, 1996
27. Turkstra F, Karemaker R, Kuijer PMM, Prins MH, Büller HR: Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different? Thromb Haemost 81: 345-348, 1999
28. Martinelli I, Cattaneo M, Panzeri D, Mannucci PM: Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism. Thromb Haemost 77: 440-443, 1997
29. Segal JB, Kasper EK, Rohde C, Bray PF, Baldwin III WM, Resar JR, Hruban RH, Kickler TS: Coagulation markers predicting cardiac transplant rejection. Transplantation 72: 233-237, 2001